AdobeStock_212192737.jpeg

Individualized treatment plans for patients

The Neuroscience Institute at Baylor Scott & White Medical Center – Temple offers the complete spectrum of diagnostics and treatment. With specialists from neurology, neurosurgery, neuro-oncology, neuropsychology and neurointerventional surgery, we offer advanced and individualized treatment plans for patients.

Learn how to lower your stroke risk with healthier habits.

Treatment and services

​​​​​​​​​​​​​

Brain and Spine Tumor Program

The Baylor Scott & White Neuroscience Institute offers expert care for patients battling tumors of the brain and spine. In collaboration with the Baylor Scott & White Cancer Institute, the Brain and Spine Tumor Program provides advanced treatment for patients with brain tumors and neurologic complications of cancer.

Our Temple brain and spine tumor program team includes:

  • Neurologists
  • Neurosurgeons
  • Neuro-oncologists
  • Radiation oncologists
  • Surgical oncologists
Most brain and spine tumor patients will be seen in the Baylor Scott & White Vasicek Cancer Treatment Center – Temple on the Temple campus. There, they meet with a team of physicians to determine the best treatment options.

Comprehensive Stroke Center

The stroke program at Baylor Scott & White Medical Center – Temple has been certified as a Comprehensive Stroke Center by Joint Commission since 2010, and has been certified as a Comprehensive Stroke Center since 2018.

This distinction is given to centers that demonstrate their stroke care program follows national standards and guidelines that can significantly improve outcomes for stroke patients.

Learn more about stroke care and support groups

Epilepsy Center

Our Level III Epilepsy Center in Temple offers advanced epilepsy treatment options

Learn more about the Epilepsy Center

Plummer Movement Disorders Center

The Baylor Scott & White Plummer Movement Disorders Center (PMDC) is part of the division of Baylor Scott & White's Neurology Department within the Neuroscience Institute. The center offers a variety of treatments for patients suffering from movement disorders.

Diagnostic methods

The full extent of a movement disorder may not be completely understood at first, but may be revealed with comprehensive medical evaluation and diagnostic testing.

Movement disorders also depend on a number of diagnostic tools, including:

  • Patient’s complete health history
  • Thorough neurological exam by a specialist
  • Complete family history
  • Magnetic resonance imaging (MRI)

Treatment options

Baylor Scott & White offers a number of treatment options to provide relief from movement disorders symptoms, including:

  • Medication to help control symptoms and manage depression or anxiety that may accompany the disorder
  • Botox injections to relieve muscle contractions and spasms
  • Lifestyle changes such as exercise, diet or stress management
  • Supportive therapies including physical therapy, occupational therapy and speech therapy
  • Surgery, depending on the extent of the symptoms
  • Deep brain stimulation, a surgical procedure used to treat certain neurologic conditions. In this type of treatment, an electrode is implanted surgically into the deep brain structures that influence movement. The conditions most commonly treated with DBS are Parkinson’s disease, dystonia and tremors

Learn more about the Plummer Movement Disorder Center

Achievements

Baylor Scott & White Medical Center – Temple's Comprehensive Stroke Center achievements include:

  • 2024 American Heart Association / American Stroke Association Get with The Guidelines Stroke Gold Plus designation, recognizing demonstrated performance for 24 or more consecutive months
  • 2024 recipient of Target Stroke Honor Roll Elite Award (American Heart Association / American Stroke Association) and Type 2 Diabetes Honor Roll Award
  • To earn this award, clot-busting (thrombolytic) medication must be delivered within 60 minutes to at least 85% of acute ischemic stroke patients.
  • In 2023, the median time for administering clot-busting medication was 39 minutes, with 96.7% of patients receiving it within 60 minutes of arriving in the emergency department and 86% of patients receiving it within 45 minutes
  • 97.8% compliance with all American Heart Association / American Stroke Association Stroke Measures in 2023
  • In 2023, 93 patients were treated with clot-busting medication, and 53 patients were treated with mechanical endovascular reperfusion therapy
  • 2023 demonstrated 4% serious complication rate for symptomatic patients that have had a carotid endarterectomy or carotid stenting procedure and 0% serious complication rate for asymptomatic patients that have had a carotid endarterectomy or carotid stenting procedure at Baylor Scott & White Medical Center – Temple. This rate is below the benchmark set forth by The Joint Commission
  • Serious complications can include stroke, death or heart attack after the procedure
  • To minimize the stroke risk, a provider may recommend the patient has a carotid endarterectomy or carotid stenting procedure to restore blood flow in the neck artery and to the brain